Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Kelly

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
Drug Discovery Today|May 19, 2019
Serendipitous drug repurposing through social mediaDaniel P Kelly, Julie Blatt
Journal of Molecular and Cellular Cardiology|December 31, 2023
Cardiac maturationTomoya Sakamoto, Daniel P Kelly
Journal of Molecular and Cellular Cardiology|November 12, 2002
Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heartBrian N Finck, Daniel P Kelly
The Journal of Clinical Investigation|February 14, 2017
Cardiac nuclear receptors: architects of mitochondrial structure and functionRick B Vega, Daniel P Kelly
JACC. Basic to Translational Science|August 1, 2018
Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?Douglas L Mann, Daniel P Kelly
Genes & Development|March 9, 2004
Transcriptional regulatory circuits controlling mitochondrial biogenesis and functionDaniel P Kelly, Richard C Scarpulla
Journal of Molecular and Cellular Cardiology|May 9, 2008
The PPAR trio: regulators of myocardial energy metabolism in health and diseaseJose A Madrazo, Daniel P Kelly
Clinical and Experimental Pharmacology & Physiology|May 3, 2002
Transcriptional activation of energy metabolic switches in the developing and hypertrophied heartJohn J Lehman, Daniel P Kelly
Circulation Research|September 18, 2004
Nuclear receptor signaling and cardiac energeticsJanice M Huss, Daniel P Kelly
The Journal of Clinical Investigation|March 15, 2005
Mitochondrial energy metabolism in heart failure: a question of balanceJanice M Huss, Daniel P Kelly
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
Drug Discovery Today|May 19, 2019
Serendipitous drug repurposing through social mediaDaniel P Kelly, Julie Blatt
Journal of Molecular and Cellular Cardiology|December 31, 2023
Cardiac maturationTomoya Sakamoto, Daniel P Kelly
Journal of Molecular and Cellular Cardiology|November 12, 2002
Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heartBrian N Finck, Daniel P Kelly
The Journal of Clinical Investigation|February 14, 2017
Cardiac nuclear receptors: architects of mitochondrial structure and functionRick B Vega, Daniel P Kelly
JACC. Basic to Translational Science|August 1, 2018
Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?Douglas L Mann, Daniel P Kelly
Genes & Development|March 9, 2004
Transcriptional regulatory circuits controlling mitochondrial biogenesis and functionDaniel P Kelly, Richard C Scarpulla
Journal of Molecular and Cellular Cardiology|May 9, 2008
The PPAR trio: regulators of myocardial energy metabolism in health and diseaseJose A Madrazo, Daniel P Kelly
Clinical and Experimental Pharmacology & Physiology|May 3, 2002
Transcriptional activation of energy metabolic switches in the developing and hypertrophied heartJohn J Lehman, Daniel P Kelly
Circulation Research|September 18, 2004
Nuclear receptor signaling and cardiac energeticsJanice M Huss, Daniel P Kelly
The Journal of Clinical Investigation|March 15, 2005
Mitochondrial energy metabolism in heart failure: a question of balanceJanice M Huss, Daniel P Kelly
Pageof 18